<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yeh CN</submitter><funding>Chang-Gung Medical Research Project</funding><funding>National Science Council of Taiwan</funding><funding>CGMH_NTHU Joint Research</funding><pagination>174-202</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5633353</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15</volume><pubmed_abstract>The data presented in this article are related to the research article entitled "Synthesis and Characterization of Boron Fenbufen and its F-18 Labeled Homolog for Boron Neutron Capture Therapy of COX-2 Overexpressed Cholangiocarcinoma". The contents of the data article include 1) the set up for performing &lt;i>in vitro&lt;/i> binding assay, 2) &lt;sup>1&lt;/sup>H-, &lt;sup>13&lt;/sup>C- and &lt;sup>19&lt;/sup>F-NMR of compounds described in main text, 3) HPLC chromatogram of the fluorination mixtures, 4) data of &lt;i>in vitro&lt;/i> stability test, cell survival assay, western blot and PCR analysis, 5) the modules for fixing the two CCA rats for BNCT, and 6) bar diagram for tumor reduction using [&lt;sup>18&lt;/sup>F]FDG-PET 24 h post treatment with BNCT.</pubmed_abstract><journal>Data in brief</journal><pubmed_title>Dataset on the synthesis and characterization of boron fenbufen and its F-18 labeled homolog.</pubmed_title><pmcid>PMC5633353</pmcid><funding_grant_id>NMRPG3F6021</funding_grant_id><funding_grant_id>CMRPG3A0512</funding_grant_id><funding_grant_id>CRRPG3F0031</funding_grant_id><funding_grant_id>CMRPG3E1612</funding_grant_id><funding_grant_id>MOST-105–2314-B-182A-041-MY2</funding_grant_id><funding_grant_id>NSC-104–2113-M-007–019</funding_grant_id><funding_grant_id>CGTH96N2342E1</funding_grant_id><pubmed_authors>Chang CW</pubmed_authors><pubmed_authors>Huang YC</pubmed_authors><pubmed_authors>Chen TW</pubmed_authors><pubmed_authors>Yu CS</pubmed_authors><pubmed_authors>Chen YR</pubmed_authors><pubmed_authors>Yeh CN</pubmed_authors><pubmed_authors>Chou YC</pubmed_authors><pubmed_authors>Chen MH</pubmed_authors><pubmed_authors>Chiang KC</pubmed_authors><pubmed_authors>Wang HE</pubmed_authors><pubmed_authors>Tien SW</pubmed_authors><pubmed_authors>Chung YH</pubmed_authors><pubmed_authors>Huang WS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Dataset on the synthesis and characterization of boron fenbufen and its F-18 labeled homolog.</name><description>The data presented in this article are related to the research article entitled "Synthesis and Characterization of Boron Fenbufen and its F-18 Labeled Homolog for Boron Neutron Capture Therapy of COX-2 Overexpressed Cholangiocarcinoma". The contents of the data article include 1) the set up for performing &lt;i>in vitro&lt;/i> binding assay, 2) &lt;sup>1&lt;/sup>H-, &lt;sup>13&lt;/sup>C- and &lt;sup>19&lt;/sup>F-NMR of compounds described in main text, 3) HPLC chromatogram of the fluorination mixtures, 4) data of &lt;i>in vitro&lt;/i> stability test, cell survival assay, western blot and PCR analysis, 5) the modules for fixing the two CCA rats for BNCT, and 6) bar diagram for tumor reduction using [&lt;sup>18&lt;/sup>F]FDG-PET 24 h post treatment with BNCT.</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Dec</publication><modification>2025-04-27T03:53:05.784Z</modification><creation>2019-03-27T02:58:30Z</creation></dates><accession>S-EPMC5633353</accession><cross_references><pubmed>29021997</pubmed><doi>10.1016/j.dib.2017.08.048</doi></cross_references></HashMap>